Tislelizumab: First Approval

This article summarises the major milestones in the development of tislelizumab for this first approval for classical Hodgkin’s lymphoma, and its potential upcoming approvals in other indications.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research